2019 ACC/AHA Guideline on the Primary Prevention of …
Statin therapy is first-line treatment for primary prevention of ASCVD in patients with elevated low-density lipoprotein cholesterol levels (≥190 mg/dL), those with diabetes mellitus, who are 40 to 75 years of age, and those determined to be at sufficient ASCVD …
Cholesterol Management: ACC/AHA Updates Guideline | AAFP
• Maximally tolerated statin therapy is recommended for patients 20 to 75 years of age with an LDL-C level of 190 mg per dL or greater. • Moderate-intensity statin therapy...
- [PDF]
2018 …
In patients with clinical ASCVD, reduce low-density lipoprotein cholesterol (LDL-C) with high-intensity statin therapy or maximally tolerated statin therapy. The more LDL-C is reduced on statin therapy, the greater will be sub-sequent risk reduction.
2019 ACC/AHA Guideline on the Primary Prevention of …
2019年3月17日 · The following are guideline recommendations for statin treatment: Patients ages 20-75 years and LDL-C ≥190 mg/dl, use high-intensity statin without risk assessment.
Statin Use for the Primary Prevention of Cardiovascular Disease in ...
2022年8月23日 · The USPSTF recommends that clinicians prescribe a statin for the primary prevention of CVD for adults aged 40 to 75 years who have 1 or more CVD risk factors (i.e. dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year risk of a cardiovascular event of 10% or greater.
USPSTF Releases Updated Statin Guidelines For Primary …
2022年8月23日 · Highlights include a recommendation that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults ages 40 to 75 years who have one or more cardiovascular disease risk factors, such as dyslipidemia, diabetes, hypertension, or smoking, and an estimated 10-year cardiovascular disease risk of 10% or greater.
Recommend statins as first-line pharmacotherapy. Consider the combination of statin and nonstatin therapy in selected patients. Discuss potential risk reduction from lipid-lowering therapy. Discuss the potential for adverse effects or drug–drug interactions. Consider cost.
Comparing Guideline Recommendations of Statin Use For the …
2022年10月4日 · The 2018 American Heart Association/American College of Cardiology/Multisociety (AHA/ACC/MS) guideline recommends statin therapy for primary prevention in adults with low density lipoprotein-cholesterol (LDL-C) >190mg/dL (Class 1), those aged 40-75 years with diabetes mellitus irrespective of ASCVD risk (Class 1), and those aged …
Statin Use for the Primary Prevention of Cardiovascular Disease in ...
The full recommendation statement is available at https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication. The USPSTF...
Guidelines for the Management of High Blood Cholesterol
2022年5月28日 · For primary prevention, a decision to initiate statin therapy is made on multiple factors (i.e., presence of diabetes or severe hypercholesterolemia, estimated 10-year risk or lifetime risk for ASCVD, presence of risk enhancing factors (e.g., metabolic syndrome and chronic kidney disease); and if in doubt, detection of subclinical atherosclerosi...